Armistice Capital, LLC Portfolio Holdings

Armistice Capital, LLC

  • $5.71 Billion
  • Q2 2025

Armistice Capital, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $5.71 Billion distributed in 210 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ptc Therapeutics, Inc. with a value of $231M, Supernus Pharmaceuticals, Inc. with a value of $152M, Immunovant, Inc. with a value of $143M, Travere Therapeutics, Inc. with a value of $131M, and Incyte Corp with a value of $91M.

Examining the 13F form we can see an decrease of $851M in the current position value, from $6.56B to 5.71B.

Armistice Capital, LLC is based out at New York, NY

Below you can find more details about Armistice Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $5.71 Billion
ETFs: $3.02 Billion
Healthcare: $1.87 Billion
Technology: $329 Million
Consumer Cyclical: $329 Million
Consumer Defensive: $85.6 Million
Communication Services: $38.9 Million
Basic Materials: $14.5 Million
Industrials: $11.9 Million
Other: $9.21 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.24B
$231 Million 4.05% of portfolio
4,735,464
Q2 2025 Reduced 12.87%
$2.21B
$152 Million 2.66% of portfolio
4,812,000
Q2 2025 Reduced 7.39%
$3.55B
$143 Million 2.5% of portfolio
5,200,000
Q2 2025 Added 15.56%
$1.12B
$131 Million 2.3% of portfolio
8,876,000
Q2 2025 Added 0.05%
$18.2B
$91 Million 1.59% of portfolio
1,336,000
Q2 2025 Reduced 20.07%
$12.3B
$85 Million 1.49% of portfolio
676,024
Q2 2025 Reduced 32.41%
$327M
$70.6 Million 1.24% of portfolio
8,881,344
Q2 2025 Added 3.66%
$7.2B
$66 Million 1.15% of portfolio
7,298,000
Q2 2025 Reduced 21.34%
$59.7B
$52.5 Million 0.92% of portfolio
100,032
Q2 2025 Reduced 12.31%
$1.72B
$48.6 Million 0.85% of portfolio
1,836,000
Q2 2025 Reduced 12.49%
$2.26T
$48.1 Million 0.84% of portfolio
219,423
Q2 2025 Reduced 16.92%
$1.32B
$47.2 Million 0.83% of portfolio
2,812,000
Q2 2025 Reduced 6.27%
$35.3B
$44.1 Million 0.77% of portfolio
80,000
Q2 2025 Reduced 18.37%
$3.23B
$43.4 Million 0.76% of portfolio
1,312,349
Q2 2025 Added 28.24%
$222B
$41.9 Million 0.73% of portfolio
143,580
Q2 2025 Added 258.95%
$3.95T
$41.7 Million 0.73% of portfolio
83,737
Q2 2025 Reduced 36.56%
$1.94B
$38.8 Million 0.68% of portfolio
1,168,000
Q2 2025 Reduced 42.97%
$3B
$38.4 Million 0.67% of portfolio
565,403
Q2 2025 Reduced 21.14%
$6.14B
$37.5 Million 0.66% of portfolio
124,000
Q2 2025 Reduced 8.75%
$362M
$36.8 Million 0.64% of portfolio
6,260,000
Q2 2025 Added 0.79%
$415M
$35.8 Million 0.63% of portfolio
6,200,000
Q2 2025 Reduced 5.66%
$1.21T
$33.6 Million 0.59% of portfolio
190,400
Q2 2025 Reduced 35.89%
$276M
$33.2 Million 0.58% of portfolio
2,978,000
Q2 2025 Added 0.47%
$195M
$27.4 Million 0.48% of portfolio
12,000,000
Q2 2025 Added 9.09%
$502M
$24.9 Million 0.44% of portfolio
2,036,000
Q2 2025 Added 1.8%
$2.71B
$25.3 Million 0.44% of portfolio
1,413,588
Q2 2025 Reduced 54.19%
$15.3B
$24.5 Million 0.43% of portfolio
280,000
Q2 2025 Reduced 14.03%
$602M
$24.4 Million 0.43% of portfolio
2,560,000
Q2 2025 Reduced 7.51%
$122B
$23 Million 0.4% of portfolio
264,000
Q2 2025 Reduced 51.22%
$3.36B
$22.6 Million 0.4% of portfolio
1,235,484
Q2 2025 Reduced 33.78%
$157B
$23.1 Million 0.4% of portfolio
59,587
Q2 2025 Reduced 46.41%
$6.82B
$22.7 Million 0.4% of portfolio
125,827
Q2 2025 Added 28.74%
$8.95B
$21.8 Million 0.38% of portfolio
200,039
Q2 2025 Reduced 42.44%
$14.3B
$21.7 Million 0.38% of portfolio
103,496
Q2 2025 Added 130.17%
$1.4B
$21.3 Million 0.37% of portfolio
678,000
Q2 2025 Reduced 30.67%
$989M
$20.5 Million 0.36% of portfolio
7,764,000
Q2 2025 New
$37.5B
$20.1 Million 0.35% of portfolio
150,000
Q2 2025 Reduced 37.5%
$3.82B
$20.2 Million 0.35% of portfolio
200,153
Q2 2025 Added 14.17%
$214M
$19.5 Million 0.34% of portfolio
2,800,000
Q2 2025 Added 4.79%
$1.19B
$18.3 Million 0.32% of portfolio
325,847
Q2 2025 Added 185.83%
$15.8B
$16 Million 0.28% of portfolio
522,038
Q2 2025 Reduced 70.49%
$346M
$15.2 Million 0.27% of portfolio
1,527,815
Q2 2025 Reduced 27.04%
$43.1B
$15.4 Million 0.27% of portfolio
64,016
Q2 2025 Reduced 38.38%
$131M
$14.9 Million 0.26% of portfolio
4,800,000
Q2 2025 Reduced 11.7%
$3.41B
$14.6 Million 0.26% of portfolio
323,559
Q2 2025 New
$354M
$13.6 Million 0.24% of portfolio
2,236,000
Q2 2025 Added 1.82%
$1.61B
$13.8 Million 0.24% of portfolio
1,629,600
Q2 2025 Reduced 67.41%
$13.4B
$12.4 Million 0.22% of portfolio
223,988
Q2 2025 Reduced 10.4%
$227M
$12.8 Million 0.22% of portfolio
1,152,335
Q2 2025 Reduced 0.11%

Summary

  • Portfolio
  • No. of Stocks 210
  • Current Value $5.71 Billion
  • Prior Value $6.56 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 62 stocks
  • Additional Purchases 39 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 74 stocks
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email